首页> 外文期刊>Peptides: An International Journal >Association of obestatin with blood pressure in the third trimesters of pregnancy.
【24h】

Association of obestatin with blood pressure in the third trimesters of pregnancy.

机译:妊娠晚期妊娠激素与血压的关系。

获取原文
获取原文并翻译 | 示例
       

摘要

Obestatin is a recently discovered 23-amino acid peptide encoded by the same gene that encodes ghrelin. It has been reported that there is a significant negative correlation between the plasma ghrelin concentration and systemic blood pressure in patients with pregnancy-induced hypertension. We investigated the plasma concentration of obestatin in 18 non-pregnant women, 18 normal pregnant women, and 15 patients with pregnancy-induced hypertension. The plasma concentrations of obestatin in these 3 groups of women were 63.4+/-9.5pg/ml, 38.1+/-6.3pg/ml, and 46.0+/-9.3pg/ml, respectively. In non-pregnant women, there was no correlation between the plasma obestatin concentration and the mean arterial pressure. However, there was a positive correlation between the plasma obestatin concentration and the mean arterial pressure in normal pregnant women and pregnant women with pregnancy-induced hypertension. These results suggest that obestatin may have some potential role in the regulation of blood pressure in normal pregnant women and women with pregnancy-induced hypertension.
机译:肥胖抑制素是最近发现的由编码生长素释放肽的相同基因编码的23个氨基酸的肽。据报道,妊娠高血压综合征患者的血浆生长素释放肽浓度与全身血压之间存在显着的负相关。我们调查了18名非孕妇,18名正常孕妇和15例妊娠高血压患者的血浆Obestatin浓度。在这三组妇女中,obestin的血浆浓度分别为63.4 +/- 9.5pg / ml,38.1 +/- 6.3pg / ml和46.0 +/- 9.3pg / ml。在未怀孕的妇女中,血浆肥胖抑制素浓度与平均动脉压之间没有相关性。但是,正常孕妇和妊娠高血压综合征孕妇的血浆雌激素浓度与平均动脉压之间存在正相关。这些结果表明,肥胖抑制素可能在正常孕妇和妊娠高血压妇女的血压调节中具有潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号